SCHEMBL3567676

SCHEMBL3567676

CC(C)(C)c1ccc(CNCCOc2ccccc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.78
GAA P10253 2/20 0.71
KDM4E B2RXH2 1/20 0.71
MITF O75030 1/20 0.71
DRD4 P21917 7/20 0.71
NPC1 O15118 1/20 0.58
POLB P06746 1/20 0.58
CASP3 P42574 1/20 0.58
RAB9A P51151 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
DRD2 P14416 4/20 0.57
DRD3 P35462 4/20 0.57
ADRA1D P25100 1/20 0.57
ADRA1A P35348 1/20 0.57
ADRA1B P35368 1/20 0.57
PPARG P37231 1/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177721 0.85 KMT2A (0.66) KMT2AGAAKDM4EMITFDRD4
SCHEMBL5176961 0.84 KMT2A (0.57) KMT2AGAAKDM4EMITFDRD4
SCHEMBL5178624 0.84 KMT2A (0.57) KMT2AGAAKDM4EMITFDRD4
SCHEMBL8740486 0.84 DRD4 (1.00) KMT2AGAADRD4DRD2DRD3
Hydrochloric Acid SCHEMBL8042280 0.83 DRD2 (0.69) KMT2AGAAKDM4EMITFDRD4
SCHEMBL5177364 0.83 KMT2A (0.56) KMT2AGAAKDM4EMITFDRD4
SCHEMBL9080658 0.81 DRD4 (0.80) KMT2AGAADRD4DRD2DRD3
SCHEMBL5175859 0.80 KMT2A (0.56) KMT2AGAAKDM4EMITFDRD4
SCHEMBL23067922 0.80 KMT2A (0.61) KMT2AGAAKDM4EMITFDRD4
SCHEMBL6832002 0.80 DRD4 (0.77) KMT2AGAAKDM4EDRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC KMT2A 341/4885GAA 450/4885KDM4E 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.